Amgen Criticizes Draft Report Before Publication

Amgen is criticizing ICER’s assessments in a recent draft report that hasn’t even been published yet. Find out more here. (Source: Jaimy Lee, MM&M, 4/5/16)

You might also be interested in:

Relentless Health Value’s Richter, #HCBiz Show!’s… August 2, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
Study: ICER Value Assessments Could Leave Medicare Part B… June 2, 2018
ICER Sets Out Against Unjustified Price Increases in New Report February 7, 2019
ICER Releases Report on Plaque Psoriasis Treatments April 28, 2018
ICER Releases Draft Evidence Report on Antiandrogen Therapies July 13, 2018
ICER CSO Ollendorf Stepping Down July 4, 2018